Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141+ dendritic cells to activate naïve and memory WT1-specific CD8+ T cells. (2020)
Attributed to:
Comprehensive analysis of T-cell receptor degeneracy and T-cell crossreactivity
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/cti2.1141
PubMed Identifier: 32547743
Publication URI: http://europepmc.org/abstract/MED/32547743
Type: Journal Article/Review
Volume: 9
Parent Publication: Clinical & translational immunology
Issue: 6
ISSN: 2050-0068